Blogs about GILD - Stockpickr! Your Source for Stock Ideas

Blogs about GILD

Blogs	Description	Date Updated
Jim Cramer’s Stop Trading! - Buy Procter & Gamble	Jim Cramer told investors on Friday’s CNBC “Stop Trading!” that this market is a true bear. He explained that oil, gas and gold are working as well as Gilead (GILD) and Pfizer (PFE). “This is a bear market that was concentrated in financials and homebuilders, now spilled over to industrials,” he said. “But really has been mauling safety, too, which is really a new trend.” Cramer pointed out that stocks like Coca-Cola (KO) and Procter & Gamble (PG) are usually the pl...	June 27, 2008
Short sellers letting up in biotechs	Filed under: Amgen Inc (AMGN), Gilead Sciences (GILD), ImClone Systems (IMCL)Short selling often tells much about what is going on in a sector, particularly when there is a common trend across the major players in that sector. The end of May short selling can now be accessed from NASDAQ. Interestingly enough, short sellers at the end of May lightened up almost across the board on major NASDAQ biotech stocks from May 15 to May 30: STOCK (Ticker) ...	June 11, 2008
Gilead Sciences (GILD) CEO/Chairman Establishes Rule 10b5-1 Stock Trading Plan	Visit StreetInsider.com at http://www.streetinsider.com/Insider+Trades/Gilead+Sciences+%28GILD%29+CEOChairman+Establishes+Rule+10b5-1+Stock+Trading+Plan/3682042.html for the full story....	May 22, 2008
Biotech expert's top contrary bets	Wall Street was disappointed at recent earnings reports from Genentech (NYSE: DNA) and Gilead Sciences (NASDAQ: GILD). In his ChangeWave Biotech Investor, biotechnology sector specialist Michael Shulman sees long-term opportunities. "Genentech is one of the greatest companies in the world -- easily the best cancer company on the planet. Analysts did not like Genentech's earnings numbers, in part because of overall revenue growth, which was quite sluggish. "However, profit growth was up 14%, k...	May 21, 2008
Jim Cramer's Lightning Round & Sudden Death	BullishFluor (FLR), Quidel (QDEL), CVS Caremark (CVS), EMC (EMC), Hewlett-Packard (HPQ), Gilead Sciences (GILD) and Marathon Oil (MRO).BearishPerficient (PRFT), Rite Aid (RAD) and Whole Foods (WFM).Sudden DeathCramer was bullish on Precision Castparts (PCP) and he was bearish on International Speedway (ISCA) and Hexcel (HXL)....	April 28, 2008
Earnings highlights: Financials, Caterpillar, Johnson & Johnson, Crocs and others	Filed under: Earnings reports, Caterpillar (CAT), Citigroup Inc. (C), Johnson and Johnson (JNJ), JPMorgan Chase (JPM), Charles Schwab Corp (SCHW), Merrill Lynch (MER), Wachovia Corp (WB), Washington Mutual (WM), Eaton Corp (ETN), Wells Fargo (WFC), Crocs Inc (CROX), Bear Stearns Cos (BSC)Here are some highlights from this past week's earnings coverage from BloggingStocks: Bear Stearns Cos. Inc. (NYSE: BSC) reported a profit that missed expectations by a penny. Caterpillar Inc. (NYSE...	April 19, 2008
Gilead Sciences (GILD) reports higher Q1 profit but outlook disappoints	Filed under: Earnings reports, Forecasts, Consumer experience, Gilead Sciences (GILD)Shares of biotechnology company Gilead Sciences Inc. (NASDAQ: GILD) have been plunging this morning, despite the firm posting better-than-expected first quarter earnings per share. Hurting the stock this morning is the company's full-year sales guidance, which was unchanged. Gilead Sciences reported late yesterday that its profit during the first-quarter jumped 22% to $496.1 million, or 51 cents per share, boost...	April 17, 2008
Gilead Sciences... The Beat Goes On (GILD)	Gilead Sciences, Inc. (NASDAQ: GILD) posted results after the close today. Its Q1 revenues surged to $1.26 billion and non-GAAP earnings was $522.1 million, or... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] ...	April 16, 2008
Picking Apart Gilead Ahead of Earnings (GILD)	After today's close, we’ll get to see earnings out of Gilead Sciences Inc. (NASDAQ: GILD). The estimates for the biopharmaceutical company from First Call are... [[ This is a content summary only. Visit my website for full links, other content, and more! ]] ...	April 16, 2008
Gilead Sciences likes taking the lead in the sector	Filed under: Gilead Sciences (GILD), Stocks to BuyReaders of this space know that biotech and pharmaceutical companies are not the preferred investment candidates, but there exceptions to the rule, and Gilead Sciences is one.Gilead Sciences, Inc. (Nasdaq: GILD) is a biopharmaceutical company that concentrates on the research, development, and marketing of anti-infective medications with a primary focus on treatments for HIV.In general, analysts see Gilead registering 25-30% revenue growth in FY ...	April 15, 2008

Enter search text here: